# drugdiscovery-covid19
Created Multiobjective de novo drug design with recurrent neural networks to generate randomized SMILES (molecules) â€¢Integrated Pathway Enrichment Analyses, Auto-Dock, and ADMET filters to test ligand binding affinity
